INS and metabolic syndrome: An additional double-blinded, randomized, placebo-controlled, phase 2 trial in severely obese patients with metabolic syndrome, tested the effects of oral FMT application derived from healthy lean donors in the setting of concurrent daily fiber supplementation, and could show an improvement in insulin sensitivity, but only in those obese patients undergoing the FMT approach and supplemented with low-fermentable fibers [114].